Skip to main content
logo
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
39,900
-300 (-0.75%)
At close: Jul 24, 2026

HEM Pharma Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Revenue
14,41212,97915,067
Revenue Growth
-9.86%-13.86%-
Gross Profit
267.64624.021,616
Operating Income
-17,064-15,583-7,682
Net Income
-25,608-23,842-7,646
Earnings Per Share
-3613.52-3389.26-1203.00
EPS Growth
---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Cash & Investments
12,46813,78511,274
Total Debt
19,43219,2557,821
Net Cash (Debt)
-6,964-5,4703,453
Net Cash Growth
---
Net Cash Per Share
-982.73-777.61543.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Operating Cash Flow
-6,733-8,345-7,680
Capital Expenditures
-11,054-9,755-4,687
Free Cash Flow
-17,787-18,100-12,367
Free Cash Flow Growth
---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingMar '26 Dec '25 Dec '24
Gross Margin
1.86%4.81%10.72%
Operating Margin
-118.40%-120.06%-50.98%
Pretax Margin
-176.45%-182.75%-50.51%
Profit Margin
-177.68%-183.69%-50.75%
FCF Margin
-123.42%-139.45%-82.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingJul '26 Dec '25 Dec '24
PS Ratio
19.8725.237.62